| __timestamp | Novartis AG | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 17345000000 | 9216000000 |
| Thursday, January 1, 2015 | 17404000000 | 8296000000 |
| Friday, January 1, 2016 | 17520000000 | 10044000000 |
| Sunday, January 1, 2017 | 17175000000 | 11560000000 |
| Monday, January 1, 2018 | 18407000000 | 10558000000 |
| Tuesday, January 1, 2019 | 14425000000 | 9351000000 |
| Wednesday, January 1, 2020 | 15121000000 | 8933000000 |
| Friday, January 1, 2021 | 15867000000 | 8284000000 |
| Saturday, January 1, 2022 | 15486000000 | 7952000000 |
| Sunday, January 1, 2023 | 12472000000 | 8200000000 |
| Monday, January 1, 2024 | 12827000000 | 8480000000 |
Infusing magic into the data realm
In the competitive landscape of the pharmaceutical industry, cost efficiency is a critical factor for success. This analysis delves into the cost of revenue trends for Novartis AG and Teva Pharmaceutical Industries Limited from 2014 to 2023. Over this period, Novartis AG consistently maintained a higher cost of revenue, peaking in 2018 with a 19% increase from 2014. However, a notable decline of 32% was observed by 2023, reflecting strategic cost management.
Conversely, Teva Pharmaceutical Industries Limited exhibited a more volatile pattern, with a significant 26% rise in 2017, followed by a gradual decrease, reaching its lowest in 2022. This fluctuation highlights the challenges faced by Teva in stabilizing its cost structure. The data underscores the importance of efficient cost management in sustaining competitive advantage in the pharmaceutical sector.
Novartis AG vs Sanofi: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Novartis AG and Bristol-Myers Squibb Company's Expenses
Cost of Revenue Comparison: Novartis AG vs Regeneron Pharmaceuticals, Inc.
Novartis AG vs Biogen Inc.: Efficiency in Cost of Revenue Explored
Novartis AG vs Jazz Pharmaceuticals plc: Efficiency in Cost of Revenue Explored
Novartis AG vs PTC Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Neurocrine Biosciences, Inc.
Teva Pharmaceutical Industries Limited vs Walgreens Boots Alliance, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Jazz Pharmaceuticals plc
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Grifols, S.A.'s Expenses
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Vericel Corporation
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Iovance Biotherapeutics, Inc.